Clinical Trials Logo

Contrast-enhanced Ultrasound clinical trials

View clinical trials related to Contrast-enhanced Ultrasound.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05957042 Recruiting - Breast Cancer Clinical Trials

Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).

Start date: September 1, 2023
Phase: Early Phase 1
Study type: Interventional

To find out if contrast enhanced ultrasound (CEUS) can be used to determine if patients receiving combined ICI therapy for triple negative breast cancer (TNBC) are responding to treatment earlier than standard of care MR or CT.

NCT ID: NCT05257694 Recruiting - Clinical trials for Hepatocellular Carcinoma

Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning

Start date: January 1, 2022
Phase:
Study type: Observational

Developing a deep learning model based on contrast-enhanced ultrasound (CEUS) to predict the prognosis of hepatocellular carcinoma (HCC) and aid choose operation decisions

NCT ID: NCT04682886 Recruiting - Focal Liver Lesions Clinical Trials

Radiomics Analysis of Focal Liver Lesions Based on Contrast-Enhanced Ultrasound Imaging

Start date: January 1, 2017
Phase:
Study type: Observational

Contrast-enhanced ultrasound (CEUS) substantially improves the potential of ultrasound (US) for the identification and characterization of focal liver lesions (FLLs). Compared to contrasted-enhanced MRI and CT, it has some unique advantages, such as the absence of ionizing radiation, and easy operability and repeatability. However, the efficacy of CEUS in diagnosing liver lesions is challenged by several factors including being highly dependent on doctor's experience, low signal-to-noise ratio, and low interobserver agreement. Therefore, it is a beneficial attempt to construct an intelligent CEUS diagnosis system using digital information technology. This study aims to collect standard data of CEUS cines recordings and develop deep learning model for accurate segmentation, detection and classification of liver lesions.

NCT ID: NCT04626115 Recruiting - Clinical trials for Contrast Enhanced Ultrasound

Diagnostic Value of Sonazoid Contrast-enhanced Ultrasound in Renal Tumors

Start date: September 1, 2020
Phase:
Study type: Observational

The incidence and mortality of renal cell carcinoma are increasing year by year. Contrast-enhanced ultrasound is helpful for early diagnosis and treatment to renal tumor, and is of great importance to distinguish benign from malignant and clinical stages